Skip to main content
BVS logo

Bioventus Inc.

BVSNASDAQHealthcareMedical Devices

$13.81Today:- (-)1Y +100.73%

As of Oct 15, 2026 close

Market cap
$978.28M
P/E (TTM)
17.96
Forward P/E
-
Dividend yield
-
52-week range
$6.47$15.89
Volume (live)
-
Avg. volume (3M)
425.51K

Bioventus (BVS) Financial Ratios

For fiscal 2025 (fiscal year ended Dec 31, 2025), Bioventus had a P/E ratio of 21.92, return on equity of 13.2% (up from -23.1%), debt-to-equity of 1.36 (down from 1.92) and a current ratio of 1.70 (up from 1.31). A current ratio of 1.70 means current assets exceed current liabilities.

Bioventus Financial Ratios Analysis

Valuation, profitability, leverage, and liquidity ratios

Income StatementBalance SheetCash FlowRatios
Scroll to see more
BreakdownFY 2025FY 2024FY 2023FY 2022FY 2021FY 2020
Period endingDec 2025Dec 2024Dec 2023Dec 2022Dec 2021Dec 2020
Valuation Ratios
P/E Ratio21.92-----
Forward P/E9.7920.0021.8217.1721.50-
P/S Ratio0.881.200.650.322.00-
P/B Ratio2.183.701.500.391.61-
Price/FCF6.9118.1641.57-90.94-
Price/OCF6.6717.6921.63-37.46-
PEG Ratio0.810.810.810.812.07-
Enterprise Value Ratios
EV/Revenue1.481.901.511.182.45-
EV/EBITDA10.8019.4826.88-25.38-
EV/EBIT14.8829.66382.69-50.07-
EV/FCF11.6328.7597.14-111.28-
Profitability & Returns
Return on Equity (ROE)13.17%-23.14%-38.27%-30.58%3.38%10.16%
Return on Assets (ROA)4.99%2.98%0.12%-1.67%1.53%2.82%
Return on Invested Capital (ROIC)11.40%6.63%0.29%-4.11%3.73%7.22%
Return on Capital Employed (ROCE)10.80%7.10%0.30%-3.20%2.00%5.90%
Leverage & Solvency Ratios
Debt/Equity1.361.921.901.060.701.42
Debt/EBITDA3.745.7911.81719.648.233.83
Debt/FCF4.329.4252.70-39.723.70
Liquidity Ratios
Current Ratio1.701.311.530.901.461.73
Quick Ratio1.120.800.910.550.931.43
Efficiency Ratios
Asset Turnover0.810.740.470.390.500.66
Inventory Turnover2.062.012.092.472.823.10
Yield & Distribution Ratios
Earnings Yield4.56%-5.26%-47.08%-98.15%2.25%-
FCF Yield14.47%5.51%2.40%-15.50%1.10%-
Payout Ratio-----121.18%
Buyback Yield-6.77%-3.03%-2.05%-35.00%-828.01%-

Source: Company financial statements from annual and quarterly filings. Data as of Jun 27, 2026. Data sources and methodology

Frequently Asked Questions About Bioventus Financial Ratios

What is Bioventus's P/E ratio?

Bioventus's P/E ratio was 21.92 for fiscal 2025 (period ended Dec 31, 2025).

What is Bioventus's return on equity?

Bioventus's return on equity (ROE) was 13.2% for fiscal 2025 (period ended Dec 31, 2025). It was -23.1% a year earlier.

What is Bioventus's debt-to-equity ratio?

Bioventus's debt-to-equity ratio was 1.36 for fiscal 2025 (period ended Dec 31, 2025). It was 1.92 a year earlier.

What is return on equity (ROE)?

Return on equity is net income divided by shareholders' equity. It measures how much profit a company generates from the capital its shareholders have invested. Full definition